These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 19396233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Determinants of rapid disease progression in ALS.
    Yamanaka K, Cleveland DW.
    Neurology; 2005 Dec 27; 65(12):1859-60. PubMed ID: 16380607
    [No Abstract] [Full Text] [Related]

  • 3. Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis.
    Crosio C, Casciati A, Iaccarino C, Rotilio G, Carrì MT.
    Cell Death Differ; 2006 Dec 27; 13(12):2150-3. PubMed ID: 16710367
    [No Abstract] [Full Text] [Related]

  • 4. Edaravone in ALS.
    Takahashi R.
    Exp Neurol; 2009 Jun 27; 217(2):235-6. PubMed ID: 19285071
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
    Kadoyama K, Funakoshi H, Ohya-Shimada W, Nakamura T, Matsumoto K, Matsuyama S, Nakamura T.
    Neurosci Res; 2009 Oct 27; 65(2):194-200. PubMed ID: 19595710
    [Abstract] [Full Text] [Related]

  • 10. Accumulation of labile zinc in neurons and astrocytes in the spinal cords of G93A SOD-1 transgenic mice.
    Kim J, Kim TY, Hwang JJ, Lee JY, Shin JH, Gwag BJ, Koh JY.
    Neurobiol Dis; 2009 May 27; 34(2):221-9. PubMed ID: 19344646
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR.
    Neurobiol Dis; 2005 Dec 27; 20(3):943-52. PubMed ID: 16046140
    [Abstract] [Full Text] [Related]

  • 13. Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?
    Butsch PO, Cudkowicz ME.
    Exp Neurol; 2007 Jul 27; 206(1):11-5. PubMed ID: 17498699
    [No Abstract] [Full Text] [Related]

  • 14. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Sharp PS, Dick JR, Greensmith L.
    Neuroscience; 2005 Jul 27; 130(4):897-910. PubMed ID: 15652988
    [Abstract] [Full Text] [Related]

  • 15. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
    Chi L, Ke Y, Luo C, Gozal D, Liu R.
    Neuroscience; 2007 Feb 09; 144(3):991-1003. PubMed ID: 17150307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J, Sanelli T, Xiao S, Yang W, Horne P, Hammond R, Pioro EP, Strong MJ.
    Neurosci Lett; 2007 Jun 13; 420(2):128-32. PubMed ID: 17543992
    [Abstract] [Full Text] [Related]

  • 18. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
    Pasinelli P, Brown RH.
    Nat Rev Neurosci; 2006 Sep 13; 7(9):710-23. PubMed ID: 16924260
    [Abstract] [Full Text] [Related]

  • 19. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J, Vannuvel K, Andries M, Waelkens E, Robberecht W, Van Den Bosch L.
    J Neurochem; 2008 Sep 13; 106(5):2170-83. PubMed ID: 18624915
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.